| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.2 |